Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.05.14.491921

The canonical HPA axis contributes to locomotion during photoadaptation but is not required

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis and its effector molecules--glucocorticoids--modulate diverse aspects of physiology in vertebrates ranging from metabolism to immune function, behavior, and circadian cycle. While the glucocorticoid receptor (nr3c1) is known to be involved in light adaptation (photoadaptation) of the retinal cells, the role of nr3c1 and other HPA axis signaling molecules in the behavioral phenotypes observed during photoadaptation have not been delineated. Therefore, we investigated locomotor adaptation to various light/dark durations using larval zebrafish that carry a mutated allele in key HPA axis receptors. First, we established baseline locomotion and compared WT and nr3c1 mutant larvae in constantly lit and dark conditions (for 12-hrs). WT larval zebrafish showed highest locomotor activity in the middle of the day and low activity during the early and later parts of the day, which was generally higher in the light. The baseline locomotion was depressed in nr3c1 mutants throughout the day in both environments with a more significant change noted in the light. Next, groups of larvae mutant in nr3c1, nr3c2 (mineralocorticoid receptor), or mc2r (melanocortin receptor type 2; adrenocorticotropic hormone (ACTH) receptor) along with their wildtype (WT) siblings were acclimated in the dark and underwent four cycles of dark-light illumination changes with different durations of illumination: 7.5, 6, 4, or 2 min. The nr3c1 and mc2r mutant fish showed significantly decreased locomotion during the dark phase when the illumination was provided for 4 or 2 min. However, with 4 min or longer illumination, if locomotor deficits were observed in mutant larvae, they demonstrated a "catch-up" phenotype with increasing locomotion during the later dark phases of the assay and ultimately reaching the swimming distances indistinguishable from their WT siblings in the assays with 7.5-min illumination. Finally, we looked at effects of light intensity, beginning with our short light exposure. A lower intensity of light failed to elicit any response even from WT fish after 1-min illumination. However, this dim light still evoked a robust response from nr3c1 mutants and their WT siblings after 7.5-min illumination. The nr3c2 mutant larvae consistently showed locomotor response similar to their WT siblings regardless of the length of the light phase. Thus, activation of the canonical HPA axis (i.e. nr3c1, mc2r) was necessary to induce a rapid locomotor adaptation following after light to dark transition with shorter light exposure times (~[≤]4 min), but it was not needed for locomotor responses observed after longer exposure to light (~> 4 min). Moreover, the locomotor response after transitioning to dark from a short (1 min) exposure was dependent on the intensity of light, whereas the longer exposure was not. Together, these findings suggest that locomotion after longer exposure to light is not dependent on the HPA axis, suggesting that either parallel independent pathway(s) are responsible for the locomotor response in these cases or that the HPA axis facilitates a primary pathway to increase sensitivity to light exposure.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lee, H. B., Dang Thi, V. H., Boyum, G. E., Modhurima, R., Hall, E. M., Green, I. K., Cervantes, E., Shams, S., Clark, K. J.. 2022-05-15. The canonical HPA axis contributes to locomotion during photoadaptation but is not required. https://doi.org/10.1101/2022.05.14.491921

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗